Biomimetic Bimetallic‐Polyphenol Network as a Novel siRNA Carrier for the Treatment of Rheumatoid Arthritis via Macrophage Repolarization
Small · 2026-01 · 22 (6)
DOI: 10.1002/smll.202509576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 08.12.2025. Verfasst von Guanxin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Macrophages, RNA, Small Interfering, Biomimetic Materials. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is an auto‐immune disease characterized by inflammatory episodes and joint degradation. Activated macrophages produce large amounts of reactive oxygen species (ROS) and pro‐inflammatory cytokines, which damage chondrocytes and destroy the cartilage matrix. Therefore, a promising therapeutic strategy for the treatment of RA is to inhibit the secretion of pro‐inflammatory cytokines and ROS to promote macrophage polarization and facilitate cartilage repair. In this paper, an active targeting nanomedicine based on metal‐phenolic networks (MPNs) is constructed to re‐polarize activated macrophages for RA therapy. Sr 2+ and Cu 2+ are first coordinated with tannic acid (TA) to prepare TSC, and TNF‐α siRNA is loaded into TSC via simple ultrasonic treatment to obtain TSSC. Finally, TSSC is coated with M1 macrophage membrane (termed as TSSC@M1) to enhance its inflammatory targeting ability. TSSC@M1 can actively target macrophages by releasing TA, Cu 2+ , and TNF‐α siRNA to synergistically scavenge ROS and inhibit the expression of TNF‐α to induce macrophage polarization, while Sr 2+ can further protect cartilage. In the collagen‐induced arthritis (CIA) mouse model, TSSC@M1 can accumulate at inflamed joints and alleviate RA symptoms by modulating macrophage phenotype and repairing cartilage. Overall, TSSC@M1 NPs offer a promising and safe approach to treat RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
- Department of Pharmacy, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning, 110024, P. R. China.
ORCID-Profile: Xiuli Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, G., Yang, H., Sun, Y., Li, X., Li, X., Liu, M., Li, D., Zhang, J., & Zhao, X. (2026). Biomimetic Bimetallic‐Polyphenol Network as a Novel siRNA Carrier for the Treatment of Rheumatoid Arthritis via Macrophage Repolarization. Small, 22(6). https://doi.org/10.1002/smll.202509576
Vancouver
Zhao G, Yang H, Sun Y, Li X, Li X, Liu M, et al. Biomimetic Bimetallic‐Polyphenol Network as a Novel siRNA Carrier for the Treatment of Rheumatoid Arthritis via Macrophage Repolarization. Small. 2026;22(6). doi:10.1002/smll.202509576
BibTeX
@article{Zhao2026,
author = {Zhao, Guanxin and Yang, Han and Sun, Yating and Li, Xinyi and Li, Xiaofang and Liu, Min and Li, Dan and Zhang, Jiulong and Zhao, Xiuli},
title = {Biomimetic Bimetallic‐Polyphenol Network as a Novel siRNA Carrier for the Treatment of Rheumatoid Arthritis via Macrophage Repolarization},
journal = {Small},
year = {2026},
volume = {22},
number = {6},
doi = {10.1002/smll.202509576}
}
EUVIMED